|

Fexofenadine Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Tanta University1
  • October 6 University1

Indications

  • Parkinson's Disease1
  • Parkinson Disease1
  • Arthritis1
  • Rheumatoid Arthritis1

Other2 trials

Fexofenadine as Adjuvant Therapy in Parkinson Disease
Phase 2/3
Fexofenadine in Patients With Active Rheumatoid Arthritis
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.